Skip Ribbon Commands
Skip to main content
CIBMTR

Study Lists

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   /   Studies   /   Clinical Outcomes Research   /   Study Lists   /   Observational Studies
  • Print
  • Share

 


Chronic Leukemia Working Committee Studies

The Chronic Leukemia Working Committee provides scientific oversight for studies related to hematopoietic cell transplantation for chronic leukemias, myelodysplastic disorders and myeloproliferative disorders. Studies related to cellular therapy evaluating chronic lymphocytic leukemia-specific questions or those aiming to compare cellular therapy approaches (e.g. CAR-T vs. allogeneic transplant) are also entertained in collaboration with the Cellular Immunotherapy for Cancer Working Committee.

Learn more about the studies conducted through the Chronic Leukemia Working Committee using the links below.

Recently Completed Studies

NumberTitleStatus
CK12-01 Optimal timing of allogeneic stem cell transplantation for chronic myeloid leukemia patients in the tyrosine kinase inhibitor era. Published
1506-01 Causes and risk factor of allogeneic hematopoietic cell transplantation failure in philadelphia chromosome-negative myeloproliferative neoplasm. Published
CK21-R1 Characteristics of CML transplanted patients in first chronic phase (CP1) prior to HCT Published
CK19-01b Outcomes of chronic neutrophilic leukemia patients who underwent allogeneic hematopoietic cell transplantation. Published
CK19-01a Outcomes after hematopoietic cell transplants for rare chronic leukemias: Evaluating outcomes of allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemias Published
CK18-02 The impact of somatic mutations on allogeneic transplant in chronic myelomonocytic leukemia. Published
CK18-01 A personalized prediction model for outcomes after allogeneic stem cell transplant in patients with myelodysplastic syndromes. Published
CK17-02 Reduced-intensity conditioning transplantation in older myelodysplastic syndrome: The effect of specific conditioning regimens on transplant outcomes. Published
CK16-02b The benefit of donor lymphocyte infusion in the tyrosine kinase inhibitors era in chronic myeloid leukemia post allogeneic hematopoietic cell transplantation. Published
CK15-03b Impact of genetic mutations on the outcomes of allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia with antecedent myeloproliferative neoplasm. Published
CK15-03a Outcome of allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia with antecedent history of philadelphia-negative myeloproliferative neoplasm. Published
CK15-01 Comparison of transplant versus non-transplant therapies for myelofibrosis. Published

Last Updated: 10/22/2020 1:37 PM
CIBMTR